Playbook
What should I actually do about Sjogren's?
Sjogren's is an autoimmune disease, overwhelmingly in women, that is best known for dry eyes and dry mouth but is really a whole-body condition with fatigue, joint pain, and a raised lymphoma risk. It is often diagnosed years late. This covers confirming it, relieving the dryness, and knowing what to watch for.
Sjogren's · reviewed July 2026 · 11 cited papers
See a clinician promptly if
- !Persistent or growing swelling of the salivary glands near the jaw or neck. Sjogren's raises the risk of B-cell lymphoma, so lasting gland swelling needs prompt evaluation.
- !New numbness, weakness, severe cough or breathlessness, or kidney symptoms. Sjogren's can involve nerves, lungs, and kidneys, and systemic involvement needs specialist assessment.
- !Pregnancy or planning pregnancy while anti-Ro/SSA positive. These antibodies carry a small risk of fetal heart block, so the pregnancy needs specialized fetal heart monitoring.
Step 1
Is it Sjogren's, or just dryness?
Dryness is common and has many causes. These are the features that point to Sjogren's rather than ordinary dry eye or medication side effects, and why objective testing matters.
Step 2
What to get checked
Diagnosis rests on objective tests, not dryness alone. These are the ones that matter.
Anti-SSA/Ro (and anti-La/SSB) antibodies
A positive anti-Ro is a central pillar of diagnosis and also flags pregnancy risk.
Objective eye tests (tear production and surface staining)
Measures actual dryness and eye-surface damage rather than relying on symptoms.
Lip (minor salivary gland) biopsy, when needed
Shows the characteristic focal inflammation and can confirm the diagnosis when antibodies are negative.
Complement levels and blood counts
Low complement, cryoglobulins, and certain blood changes flag higher lymphoma risk and systemic activity.
Step 3
What good treatment looks like
Treatment follows a ladder: relieve the dryness first, protect your teeth and eyes, and reserve systemic drugs for internal-organ involvement.
Dry eye care, stepping up as needed
Start with preservative-free artificial tears; if that is not enough, prescription anti-inflammatory drops such as cyclosporine are an evidence-backed next step, and punctal plugs can help retain tears.
TimelineAnti-inflammatory drops can take weeks to months.
How to get itOver the counter, then prescription.
Dry mouth care and dental protection
Frequent sips, saliva substitutes, and saliva-stimulating pills like pilocarpine or cevimeline (when glands still function) help, and rigorous dental prevention is essential because dryness causes rapid tooth decay.
How to get itOver the counter and prescription; regular dental care.
CautionsPilocarpine can cause sweating and flushing and is not for everyone.
Systemic drugs for organ involvement
When Sjogren's affects joints, nerves, lungs, or kidneys, immunosuppressants are used, guided by EULAR recommendations. These are reserved for systemic disease rather than dryness alone.
How to get itPrescription, specialist-managed.
Hydroxychloroquine, with realistic expectations
Often prescribed, but a rigorous randomized trial (JOQUER) found it no better than placebo for dryness, pain, and fatigue. It may still be used for joint symptoms, but ask what it is meant to achieve for you.
Set your expectations
- The mainstay is relieving dryness and protecting your eyes and teeth, not a cure.
- Fatigue is a major, common part of the disease and is tied to pain and mood, so it is worth addressing directly.
- Dental decay accelerates with dry mouth, so consistent dental prevention is not optional.
- Systemic drugs are reserved for internal-organ involvement, not routine dryness.
Step 4
Take this to your doctor
“I have had dry eyes and dry mouth for months along with fatigue, and I would like to be properly tested for Sjogren's rather than just treating the dryness.”
Questions to ask
- Have I had the anti-SSA/Ro antibody test, and do I need a lip biopsy or eye-surface testing?
- What is the stepwise plan for my dry eyes and dry mouth?
- Do I have any lymphoma risk markers we should monitor, like gland swelling or low complement?
- If I am anti-Ro positive and may become pregnant, what monitoring do I need?
What to bring
- A timeline of when your dryness and fatigue began
- A list of medications, since many worsen dryness
- Notes on any gland swelling, joint, nerve, or breathing symptoms
When to push. Ask for evaluation of any persistent gland swelling (lymphoma risk) and for maternal-fetal medicine input if you are anti-Ro positive and pregnant or planning pregnancy.
Step 5
Where the science is going
B-cell-targeting biologics
Most drug trials in Sjogren's have failed, but newer B-cell-depleting therapies such as ianalumab have shown early promise for systemic disease in mid-stage trials. They are still investigational, not standard care.
All sources
Every claim above links to peer-reviewed research. Full list below.
- 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts (2017). Arthritis & Rheumatology. doi.org/10.1002/art.39859
- Primary Sjögren's Syndrome (2018). New England Journal of Medicine. doi.org/10.1056/NEJMcp1702514
- Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease (2000). Ophthalmology. doi.org/10.1016/s0161-6420(99)00176-1
- Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group (1999). Archives of Internal Medicine. doi.org/10.1001/archinte.159.2.174
- Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors (2006). Annals of the Rheumatic Diseases. doi.org/10.1136/ard.2005.041186
- Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial (2014). JAMA. doi.org/10.1001/jama.2014.7682
- EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies (2020). Annals of the Rheumatic Diseases. doi.org/10.1136/annrheumdis-2019-216114
- Prevalence, severity, and predictors of fatigue in subjects with primary Sjögren's syndrome (2008). Arthritis & Rheumatism (Arthritis Care & Research). doi.org/10.1002/art.24311
- Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry (1998). Journal of the American College of Cardiology. doi.org/10.1016/s0735-1097(98)00161-2
- Diagnostic Delay in Patients with Primary Sjögren's Syndrome: A Population-Based Cohort Study in Taiwan (2021). Healthcare (Basel). doi.org/10.3390/healthcare9030363
- Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial (2022). The Lancet. doi.org/10.1016/S0140-6736(21)02251-0
This playbook is educational and is not medical advice. Hair loss has many causes and individual treatment decisions belong with a clinician who can examine you.